Nevro Corp (NVRO)
3.71
0.00 (0.00%)
USD |
NYSE |
Jan 03, 16:00
3.70
-0.01
(-0.27%)
Pre-Market: 20:00
Nevro Research and Development Expense (Annual): 54.42M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Inspire Medical Systems Inc | 116.54M |
Inari Medical Inc | 87.53M |
Stereotaxis Inc | 10.27M |
Electromed Inc | 0.656M |
Myomo Inc | 2.636M |